INTELLIGENT BIO SOLUTIONS INC.: 10-Q filed 2021-05-13
What INTELLIGENT BIO SOLUTIONS INC. reported in its quarterly report filed 2021-05-13 (fiscal Q3 2021): 23 published measures, 71 facts as tagged in accession 0001493152-21-011202.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2021-05-13
- Fiscal period
- fiscal Q3 2021
- Accession
- 0001493152-21-011202 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INTELLIGENT BIO SOLUTIONS INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 17,452,678 | USD | |
| At 2020-06-30 | 2,475,640 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 1,577,262 | USD | |
| At 2020-06-30 | 7,690,468 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 15,929,411 | USD | |
| At 2020-06-30 | -5,186,517 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 14,261,622 | USD | |
| At 2020-06-30 | 427,273 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-03-31 | -3,127,813 | USD | 90 |
| 2020-07-01 to 2021-03-31 | -6,184,287 | USD | 274 |
| 2020-01-01 to 2020-03-31 | -112,592 | USD | 91 |
| 2019-07-01 to 2020-03-31 | -2,706,760 | USD | 275 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2021-03-31 | -9,613,666 | USD | 274 |
| 2019-07-01 to 2020-03-31 | -693,593 | USD | 275 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-03-31 | 34,290 | USD | 90 |
| 2020-07-01 to 2021-03-31 | 372,754 | USD | 274 |
| 2020-01-01 to 2020-03-31 | -1,533 | USD | 91 |
| 2019-07-01 to 2020-03-31 | 119,744 | USD | 275 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2021-03-31 | 23,402,918 | USD | 274 |
| 2019-07-01 to 2020-03-31 | 532,348 | USD | 275 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | -22,016,804 | USD | |
| At 2020-06-30 | -15,832,517 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-03-31 | -3,140,515 | USD | 90 |
| 2020-07-01 to 2021-03-31 | -4,720,836 | USD | 274 |
| 2020-01-01 to 2020-03-31 | -28,824 | USD | 91 |
| 2019-07-01 to 2020-03-31 | -2,348,100 | USD | 275 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 16,586,011 | USD | |
| At 2020-06-30 | 2,339,948 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 1,559,134 | USD | |
| At 2020-06-30 | 7,690,468 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-03-31 | 3,174,805 | USD | 90 |
| 2020-07-01 to 2021-03-31 | 5,093,590 | USD | 274 |
| 2020-01-01 to 2020-03-31 | 27,291 | USD | 91 |
| 2019-07-01 to 2020-03-31 | 2,467,844 | USD | 275 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 11,881,322 | shares | |
| At 2020-06-30 | 8,630,000 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 38,440,097 | USD | |
| At 2020-06-30 | 10,899,942 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | -642,695 | USD | |
| At 2020-06-30 | -363,951 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 15,875,416 | USD | |
| At 2020-12-31 | 18,782,015 | USD | |
| At 2020-09-30 | -3,047,566 | USD | |
| At 2020-06-30 | -5,214,828 | USD | |
| At 2020-03-31 | -5,884,394 | USD | |
| At 2019-12-31 | -5,874,208 | USD | |
| At 2019-09-30 | -3,887,891 | USD | |
| At 2019-06-30 | -3,977,139 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 866,667 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-03-31 | -3,142,667 | USD | 90 |
| 2020-07-01 to 2021-03-31 | -6,209,971 | USD | 274 |
| 2020-01-01 to 2020-03-31 | -111,107 | USD | 91 |
| 2019-07-01 to 2020-03-31 | -2,728,970 | USD | 275 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-03-31 | -3,142,667 | USD | 90 |
| 2020-07-01 to 2021-03-31 | -6,209,971 | USD | 274 |
| 2020-10-01 to 2020-12-31 | -1,990,389 | USD | 92 |
| 2020-07-01 to 2020-09-30 | -1,076,915 | USD | 92 |
| 2020-01-01 to 2020-03-31 | -111,107 | USD | 91 |
| 2019-07-01 to 2020-03-31 | -2,728,970 | USD | 275 |
| 2019-10-01 to 2019-12-31 | -1,853,033 | USD | 92 |
| 2019-07-01 to 2019-09-30 | -764,830 | USD | 92 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-03-31 | 1,013,389 | USD | 90 |
| 2020-07-01 to 2021-03-31 | 2,205,842 | USD | 274 |
| 2020-01-01 to 2020-03-31 | 53,842 | USD | 91 |
| 2019-07-01 to 2020-03-31 | 1,752,182 | USD | 275 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-03-31 | -2,152 | USD | 90 |
| 2020-07-01 to 2021-03-31 | -1,489,135 | USD | 274 |
| 2020-01-01 to 2020-03-31 | -82,283 | USD | 91 |
| 2019-07-01 to 2020-03-31 | -380,870 | USD | 275 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2021-03-31 | 185,301 | USD | 274 |
| 2019-07-01 to 2020-03-31 | 249,627 | USD | 275 |
Inspect the source
- Entity
- INTELLIGENT BIO SOLUTIONS INC. / CIK 0001725430
- Captured
- 2026-09-21T17:27:32.532Z
- SEC response SHA-256
853a52aa5d475439c28611414a5b3e3bab760df6971e6f435df2e4acd29b2f46
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001725430.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))